Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/138990
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy |
Otros títulos: | Properdin in C3 glomerulopathy | Autor: | Corvillo, Fernando; Bravo García-Morato, María; Nozal, Pilar; Garrido, Sofía; Tortajada, Agustín CSIC ORCID; Rodríguez de Córdoba, Santiago ; López-Trascasa, Margarita | Palabras clave: | Alternative pathway C3 nephritic factor C3 glomerulopathy Complement C3 glomerulonephritis Properdin |
Fecha de publicación: | abr-2016 | Editor: | John Wiley & Sons | Citación: | Clin Exp Immunol. 184(1):118-25 (2016) | Resumen: | Properdin (P) stabilizes the alternative pathway (AP) convertases, being the only known positive regulator of complement system. In addition, P is a pattern recognition molecule able to initiate directly the AP on non-self surfaces. Although P deficiencies are long time known to be associated with Neisseria infections and P is often found deposited at sites of AP activation and tissue injury, the potential role of P in the pathogenesis of complement dysregulation associated disorders has not been extensively studied. Serum P levels were measured in 49 patients with histological and clinical evidence of C3 glomerulopathy (C3G). Patients were divided in two groups according to the presence or absence of C3 nephritic factor (C3NeF), an autoantibody that stabilizes the AP C3 convertase. The presence of this autoantibody results in a significant reduction in circulating C3 (p<0.001) and C5 levels (p<0.05), but does not alter factor B, P and sC5b-9 levels. Interestingly, in our cohort, serum P levels were low in 17 of the 32 C3NeF-negative patients. This group exhibited significant reduction of C3 (p<0.001) and C5 (p<0.001), and increase of sC5b-9 (p<0.001) plasma levels, compared to the control group. Besides, P consumption was significantly correlated with C3 (r= 0.798, p 0.0001), C5 (r= 0.806, p<0.0001), sC5b-9 (r = -0.683, p 0.043) and a higher degree of proteinuria (r= -0.862, p 0.013). These results further illustrate the heterogeneity among C3G patients and suggest that P serum levels could be a reliable clinical biomarker to identify patients with underlying surface AP C5 convertase dysregulation. | Descripción: | 24 p.-3 fig.-3 tab. | Versión del editor: | http://dx.doi.org/ 10.1111/cei.12754 | URI: | http://hdl.handle.net/10261/138990 | DOI: | 10.1111/cei.12754 | ISSN: | 0009-9104 | E-ISSN: | 1365-2249 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
serum_properdin_Corvillo.pdf | 4,26 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
15
checked on 04-abr-2024
SCOPUSTM
Citations
21
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
21
checked on 27-feb-2024
Page view(s)
236
checked on 18-abr-2024
Download(s)
318
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.